2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Blepharospasm: new trials by email Literature Review of Blepharospasm trials Research Report on Blepharospasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acetyl Hexapeptide-8 for Blepharospasm Topical acetyl hexapeptide-8, Placebo - Focal Dystonia | Phase 2 | Terminated | National Institute of Neurological Disorders and Stroke (NINDS) | 8 | 2012-11-01 | 2016-11-10 |
| Blepharospasm Short Interval NT 201 - Blepharospasm | Phase 2 | Terminated | Merz Pharmaceuticals GmbH | 8 | 2007-08-01 | 2012-02-06 |
Dystonia (1) · Dystonic Disorders (1)
Eye Diseases (2) · Eyelid Diseases (2) · Central Nervous System Diseases (1) · Dyskinesias (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Botulinum Toxins, Type A (1) · acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide (1) · incobotulinumtoxinA (1)
Merz Pharmaceuticals GmbH (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1)
Germany (1) · United States (1)
Bettina Wabbels, MD (1) · Codrin I Lungu, M.D. (1)